Eli

Eli Health is a provider of AI-based smart devices for at-home hormone monitoring, enabling women to track their hormonal health in real time. The company offers a point-of-care device that provides everyday hormone profiles from saliva samples, with results available within 20 minutes. Eli current product line includes cortisol tests for stress and recovery monitoring, with progesterone tests for cycle balance and hormonal shifts, and testosterone tests for strength and energy in pre-order. The platform features the HORMOMETER system that helps users understand patterns driving their health by establishing personal baselines and connecting how they feel to actual hormonal activity. Eli differentiates itself through evidence-based hormone insights, saliva-based testing that avoids the invasiveness of blood draws, and an AI-powered mobile app that interprets collected data to guide daily health decisions including stress reduction, sleep improvement, weight management, and training optimization. Founded in 2019 and headquartered in Montreal, Canada, Eli has raised approximately 0 million in a Series A round with investors including Real Ventures, Panache Ventures, 2048 Ventures, Muse Capital, Cake Ventures, Rhia Ventures, Telus, BDC, and Leva Capital.